Reaction
Tumour Inflammation reporting signals
As of the last recalculation, Tumour Inflammation appears in 105 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is ALPELISIB (PRR 70.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alpelisib | 3 | 70.2 | 70.2 |
| Atezolizumab | 12 | 69.0 | 69.1 |